Hu D - Search Results

1

The regulation of the cell cycle and epithelial-mesenchymal transition through FUCA2/GGH signaling promotes the progression of lung adenocarcinoma.

Peng Y, Yang X, Liu Y, Zhou J, Guo J, Ma B, Bai Y, Wu J, Hu D. Peng Y, et al. Among authors: hu d. Gene. 2025 Mar 5;939:149183. doi: 10.1016/j.gene.2024.149183. Epub 2024 Dec 20. Gene. 2025. PMID: 39710011

2

SPOCK1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion.

Liu Y, Han T, Wu J, Zhou J, Guo J, Miao R, Xu Z, Xing Y, Bai Y, Hu D. Liu Y, et al. Among authors: hu d. J Transl Med. 2023 Dec 12;21(1):909. doi: 10.1186/s12967-023-04616-3. J Transl Med. 2023. PMID: 38087364 Free PMC article.

3

RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness.

Liu Y, Han T, Miao R, Zhou J, Guo J, Xu Z, Xing Y, Bai Y, Wu J, Hu D. Liu Y, et al. Among authors: hu d. BMC Cancer. 2024 Jan 2;24(1):7. doi: 10.1186/s12885-023-11761-x. BMC Cancer. 2024. PMID: 38167018 Free PMC article.

4

CDC45 promotes the stemness and metastasis in lung adenocarcinoma by affecting the cell cycle.

Liu Y, Han T, Xu Z, Wu J, Zhou J, Guo J, Miao R, Xing Y, Ge D, Bai Y, Hu D. Liu Y, et al. Among authors: hu d. J Transl Med. 2024 Apr 8;22(1):335. doi: 10.1186/s12967-024-05038-5. J Transl Med. 2024. PMID: 38589907 Free PMC article.

5

SSBP1 positively regulates RRM2, affecting epithelial mesenchymal transition and cell cycle arrest in human lung adenocarcinoma cells.

Yang X, Ma B, Liu Y, Zhou J, Guo J, Peng Y, Bai Y, Wu J, Hu D. Yang X, et al. Among authors: hu d. Cell Signal. 2024 Dec 4;127:111552. doi: 10.1016/j.cellsig.2024.111552. Online ahead of print. Cell Signal. 2024. PMID: 39643024

6

Identification of Key Genes Driving Tumor Associated Macrophage Migration and Polarization Based on Immune Fingerprints of Lung Adenocarcinoma.

Wu J, Zhou J, Xu Q, Foley R, Guo J, Zhang X, Tian C, Mu M, Xing Y, Liu Y, Wang X, Hu D. Wu J, et al. Among authors: hu d. Front Cell Dev Biol. 2021 Nov 4;9:751800. doi: 10.3389/fcell.2021.751800. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34805160 Free PMC article.

7

Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma.

Liu Y, Zhou J, Wu J, Zhang X, Guo J, Xing Y, Xie J, Bai Y, Hu D. Liu Y, et al. Among authors: hu d. Cancer Control. 2023 Jan-Dec;30:10732748221150227. doi: 10.1177/10732748221150227. Cancer Control. 2023. PMID: 36625357 Free PMC article.

8

An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma.

Han T, Liu Y, Wu J, Bai Y, Zhou J, Hu C, Zhang W, Guo J, Wang Q, Hu D. Han T, et al. Among authors: hu d, hu c. Sci Rep. 2023 Mar 29;13(1):5153. doi: 10.1038/s41598-023-32276-2. Sci Rep. 2023. PMID: 36991102 Free PMC article.

9

A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages.

Bai Y, Zhang X, Zhou J, Guo J, Liu Y, Liang C, Wang W, Xing Y, Wu J, Hu D. Bai Y, et al. Among authors: hu d. Chem Biol Interact. 2023 Sep 1;382:110543. doi: 10.1016/j.cbi.2023.110543. Epub 2023 May 30. Chem Biol Interact. 2023. PMID: 37263557

10

Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer.

Bai Y, Liang C, Zhou J, Liu Y, Wang F, Gao J, Wu J, Hu D. Bai Y, et al. Among authors: hu d. Eur J Med Chem. 2023 Nov 5;259:115656. doi: 10.1016/j.ejmech.2023.115656. Epub 2023 Jul 17. Eur J Med Chem. 2023. PMID: 37499289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,403 results

Search Page

Filters